SBC Medical Group Holdings (SBC) Lytham Partners Fall 2026 Investor Conference summary

Business overview and strengths

• Operates the largest aesthetic medical group in Japan, with over 280 clinics and 6.9 million annual patients.

• High customer repeat rate and efficient, asset-light platform drive steady growth.

• AI integration enhances operational efficiency and customer experience.

Growth drivers and expansion plans

• Core business remains Japanese aesthetic medicine, but expanding into non-aesthetic areas like dentistry, orthopedics, and reproductive treatments.

• International expansion focuses on the U.S. and Southeast Asia, leveraging partnerships and brand diversification.

• Longevity market seen as a major future opportunity, with plans to leverage existing clinics and first-mover advantage in Japan.

AI and operational efficiency

• AI tools improve customer service, clinic network expansion, and cost efficiency.

• Announced $15 million annual service fee increase attributed to AI-driven scalability.

• AI-driven revenue growth flows directly to profit and EPS due to minimal incremental costs.